Prospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Dec 14, 2016; 22(46): 10232-10241
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10232
Table 1 Patient characteristics and clinical findings
VariableNumber of patients
SexMale46
Female19
Age (yr; mean, range)58.8; 33-76
GastrectomyDistal29
Total32
None4
Surgical curabilityR057
R10
R28
Clinical courseSurvival without relapse47
Survival after relapse2
Survival after non-curative surgery1
Decease15
Recurrence site (including overlap)None47
Remnant stomach1
Hematogenous5
Lymphatic4
Peritoneal dissemination5
Non-curative surgery8
Postoperative chemotherapyNone37
Adjuvant chemotherapy11
Adjuvant and therapeutic chemotherapy9
Therapeutic chemotherapy after non-curative surgery8
TNM stageI40
II6
III10
IV9
Depth of tumour invasionT136
T28
T39
T412
Lymph node metastasisN039
N15
N26
N315
Distant metastasisM056
M19
Main histological typeDifferentiated25
Undifferentiated40
Lymphatic invasionL035
L126
LX4
Venous invasionV035
V1-226
VX4